A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
The objective of this monograph is to provide an overview of the scope of allergic disorders, and review the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, we will limit our discussion to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved will be reviewed, particularly the relationship between allergic rhinitis and asthma. Part I includes the current evaluation, including historical features, exposures, physical exam findings, and ancillary diagnostic options will be reviewed.
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
Update your knowledge on current issues in reproductive health at the annual Contraceptive Technology conference. The Washington, DC, session is scheduled for Feb. 29-March 3, with the San Francisco session set for March 24-27.
Will adding male programs to existing family planning services subtract from existing care?
Review the number of services offered at your family planning agency, then check off the number that address the reproductive health needs of men. If your agency is like most of the facilities participating in a recently published survey, you may be serving some male patients, but doing very little to recruit more.
